- 301. Medical Specialty
- [An entity, facility, or distinct part of a facility providing diagnostic, treatment, and prescriptive services related to a specific area of medical specialization. Frequently used for Title V related Children's Specialty services or to meet specific public health needs (e.g., infectious diseases or breast and cervical cancer). ( HL7V3.0 )] (UMLS (HL7) C1552531) =Manufactured Object; Health Care Related Organization =Clinic/Center;
| - 351. Medroxyprogesterone/Mitomycin/Vinblastine
- (UMLS (NCI) C0280017) =Therapeutic or Preventive Procedure
|
- 302. Medical Status Altered
- [The medical condition of the Patient has changed ( HL7V3.0 )] (UMLS (HL7) C1555023) =Idea or Concept =SchedulingActReason;
| - 352. Medroxyprogesterone/Tamoxifen
- (UMLS (NCI) C0279126) =Therapeutic or Preventive Procedure
|
- 303. Medical Supervision Required
- (UMLS (HL7) C1546852) =Idea or Concept =Living Dependency;
| - 353. medulla oblongata
- [caudal subdivision of the hindbrain interposed between the spinal cord and the pons; adult derivative of the myelencephalon, the most caudal subdivision of the developing brain; it has two subdivisions the open medulla bordering on the fourth ventricle and the closed medulla which surrounds the rostral part of the central canal. ( CSP )] (UMLS (CSP) C0025148) =Body Part, Organ, or Organ Component =hind brain;
=Nucleus of the Solitary Tract;
area postrema;
Hypoglossal Nucleus;
dorsal motor nucleus;
|
- 304. medical supply
- [ ] (UMLS (CSP) C0740043) =Medical Device ;
| - 354. Medulla Spinalis
- [that part of the central nervous system which is lodged in the vertebral canal; it is composed of an inner core of gray matter in which nerve cells predominate, and an outer layer of white matter in which myelinated nerve fibers predominate; it is enclosed in three protective membranes, the meninges. ( CSP )] (UMLS (NCI) C0037925) =Body Part, Organ, or Organ Component ;
=Body Part;
central nervous system =dorsal root;
Ventral Nerve Root;
dorsal horn;
dorsal column;
ventral column |
- 305. Medical Technologist
- (UMLS (HL7) C1611833) =Intellectual Product ;
=Specialist/Technologist, Pathology;
| - 355. Medullary
- (UMLS (HL7) C1550278) =Body Part, Organ, or Organ Component =Body Part;
|
- 306. Medical Technologist
- [A person with professional knowledge and competence in the field of medical technology that involves performing, advising on, or supervising clinical laboratory testing of human specimens, fluids and tissues, establishing and monitoring quality control systems and measures; developing data which may be used in clinical setting and in support of medical research in such areas as hematology, bacteriology, mycology, virology, parasitology, immunology, serology, immunohematology, clinical chemistry, endocrinology and toxicology, and urinalysis as they relate to clinical laboratory practice. The concept does not refer to professionals primarily involved in technical support work concerned with operating medical machines or instruments as part of the examination or treatment of patients. ( NCI )] (UMLS (NCI) C0260281) =Professional or Occupational Group
| - 356. MEDULLARY CYSTIC KIDNEY
- (UMLS (ICD9CM) C0687120) =Congenital Abnormality; Disease or Syndrome
|
- 307. Medical Toxicology
- (UMLS (HL7) C1555739) =Intellectual Product =Emergency Medicine;
◊ [Medical Toxicologists evaluate and manage patients with accidental or intentional poisoning through exposure to prescription and non-prescription medications, drugs of abuse, household or industrial toxins, and environmental toxins. These physicians provide consultations through affiliations with regional poison control centers or within their respective medical institutions. The more important areas of Medical Toxicology include but are not limited to the following list subjects: acute pediatric and adult drug ingestion; drug abuse, addiction, and withdrawal; chemical poisoning exposure and toxicity; hazardous materials exposure and toxicity; occupational toxicology; biological poisons; basic concepts of toxicology such as kinetics, dose-response relationships, indices of toxicity and safety standards; basic principles of poison prevention; basic principles of toxic exposure and preventive methodologies.ACGME Accredited Residency Program Requirements: Medical Toxicology (EM) 2 years with 3-4 years Emergency Medicine for a total of 5-6 years; for Medical Toxicology (Preventive Medicine) 2 years with 3 years Preventive Medicine for a total of 5 years. Medical Toxicology (Pediatrics): None.ABMS Approved Subspecialty Certificates (Emergency Medicine) (Pediatrics) (Preventive Medicine) ( HL7V3.0 )] (UMLS (HL7) C1555830) Intellectual Product Pediatrics; ◊ (UMLS (HL7) C1555854) Intellectual Product Preventive Medicine; | - 357. Medullary Portion of Kidney
- [internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces. ( CSP )] (UMLS (NCI) C0022664) =Body Part, Organ, or Organ Component =kidney;
|
- 308. Medical Treatment - Refusal
- (UMLS (HL7) C1548882) =Health Care Activity =Consent Type;
| - 358. Medullary Thymoma
- [A thymic epithelial neoplasm characterized by the presence of spindle and/or oval neoplastic epithelial cells. Lymphocytic infiltration is minimal or absent. It may be associated with myasthenia gravis or pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. Approximately 20% of the cases occur as stage II or stage III tumors. Type A thymoma generally behaves as a benign tumor and the overall survival is reported to be 100% at 5 and 10 years. ( NCI )] (UMLS (NCI) C1266091) Spindle Cell Thymoma;
Thymoma Type A =Neoplastic Process |
- 309. Medical visit on same day as a type "T" or "S" procedure without modifier 25 (see Appendix B)
- (UMLS (HL7) C1547464) =Intellectual Product =OCE Edit Code;
| - 359. MEDULLOADRENAL HYPERFUNC
- [ ] (UMLS (ICD9CM) C0154206) =Disease or Syndrome
|
- 310. Medical-Surgical
- (UMLS (HL7) C1552239) =Professional or Occupational Group =Clinical Nurse Specialist;
| - 360. Medulloblastoma
- [malignant cerebellar neoplasm composed of undifferentiated neuroepithelial cells that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood; tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. ( CSP )] (UMLS (NCI) C0025149) =Neoplastic Process =brain neoplasm;
Cerebellar Diseases;
glial cell tumor;
Central Nervous System PNET |
- 311. Medical-Surgical
- (UMLS (HL7) C1555987) =Intellectual Product =Registered Nurse;
| - 361. Medulloblastoma with Extensive Nodularity and Advanced Neuronal Differentiation
- [A medulloblastoma characterized by nodularity and neuronal differentiation. Ganglion cells may be present. ( NCI )] (UMLS (NCI) C1334970) Nodular Medulloblastoma =Neoplastic Process
|
- 312. MedicalDevice
- [A device with direct or indirect therapeutic purpose. Values for EntityCode when EntityClass = "DEV" ( HL7V3.0 )] (UMLS (HL7) C1698181) =Intellectual Product ;
=MaterialEntityClassType;
=AccessMedicalDevice;
AdministrationMedicalDevice | - 362. Medulloblastoma with Leptomeningeal Spread
- [A medulloblastoma which has spread from its original site to the leptomeninges surrounding the brain and spinal cord. ( NCI )] (UMLS (NCI) C1334685) =Neoplastic Process
|
- 313. medically disadvantaged population
- [human populations that have not received adequate medical attention or health care facilities. ( CSP )] (UMLS (CSP) C0872319) medically underserved population;
Medically Underserved Populations;
Underserved Population;
Underserved Populations =Population Group ;
=named group;
| - 363. Medullomyoblastoma
- [A rare malignant embryonal neoplasm arising from the cerebellum. It is characterized by the morphologic features of a medulloblastoma and the presence of a striated muscle component. Its clinical behavior is similar to medulloblastoma. ( NCI )] (UMLS (NCI) C0205833) =Neoplastic Process ;
|
- 314. Medically Fragile Infants and Children Day Care
- [An entity, facility, or distinct part of a facility specially equipped and staffed to provide care for medically fragile hildren with varied and complex care needs (e.g., enteral or parental feeding, ostomy care, respiratory/ventilator care, medications and therapies, etc.). ( HL7V3.0 )] (UMLS (HL7) C1552532) =Intellectual Product ;
=Clinic/Center;
| - 364. Meeting
- [The act or process or an instance of coming together. ( NCI )] (UMLS (NCI) C0556656) =Health Care Activity
|
- 315. Medically Necessary Duplicate Procedure Reason for suggested values. User-define
- (UMLS (HL7) C1547854) =Therapeutic or Preventive Procedure =HL7 Vocabulary Version 2.5;
| - 365. meeting/conference/symposium
- [ ] (UMLS (CSP) C0178739) =Human-caused Phenomenon or Process ;
=information dissemination;
=workshop;
|
- 316. Medicare
- [A program under the U.S. Social Security Administration that reimburses hospitals and physicians for medical care provided to qualifying people over 65 years old. ( NCI )] (UMLS (HL7) C0018717) =Regulation or Law ;
=Government reimbursement program;
◊ (UMLS (HL7) C1546906) Health Care Related Organization DRG Payor; ◊ (UMLS (HL7) C1547152) Intellectual Product Code; | - 366. Meewoc
- (UMLS (HL7) C1551933) Mewoc;
=Language =EasternMiwok;
|
- 317. Medicare claim status
- (UMLS (HL7) C1546914) =Finding =Insurance Company Contact Reason;
| - 367. Mefenidil
- (UMLS (NCI) C0065869) =Organic Chemical; Pharmacologic Substance ;
|
- 318. Medicare Defined Swing Bed Unit
- [A unit of a hospital that has a Medicare provider agreement and has been granted approval from HCFA to provide post-hospital extended care services and be reimbursed as a swing-bed unit.Source: Code of Federal Regulations #42, Section 482.66. ( HL7V3.0 )] (UMLS (HL7) C1552461) =Intellectual Product ;
=Hospital unit;
| - 368. MEFLOQUINE
- [A phospholipid-interacting antimalarial drug (ANTIMALARIALS). It is very effective against PLASMODIUM FALCIPARUM with very few side effects. ( MSH )] (UMLS (NCI) C0025153) =Organic Chemical; Pharmacologic Substance ;
=Antimalarials;
1 benzazine =DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol Monohydrochloride |
- 319. Medicare number
- (UMLS (HL7) C1548641) =Intellectual Product =Practitioner ID number type;
| - 369. Mefoxin
- (UMLS (NCI) C0701380) =Organic Chemical; Antibiotic
|
- 320. Medicare secondary payer alert
- (UMLS (HL7) C1547484) =Intellectual Product =OCE Edit Code;
| - 370. MEG
- [A drug that belongs to the group of hormones called progestins, used as hormone therapy to block estrogen and to suppress the effects of estrogen and androgens. It is also used to stimulate the appetite in people with cancer. ( NCI )] (UMLS (NCI) C0025175) =Steroid; Pharmacologic Substance; Hormone =Pregnadienes;
[HS800] PROGESTINS =(9beta,10alpha)-17-(Acetyloxy)-6-methylpregna-4,6-diene-3,20-dione |
- 321. Medicare/CMS (formerly HCFA)_s Universal Physician Identification numbers
- (UMLS (HL7) C1549754) =Idea or Concept =Identifier type;
| - 371. MeG DNA methyltransferase
- [ ] (UMLS (CSP) C0872349) =Amino Acid, Peptide, or Protein; Enzyme
|
- 322. Medicare/Medicaid
- [both terms are federal programs, as amendments to the Social Security Act, that provides health insurance benefits; Medicaid provides health care benefits to indigent and medically indigent persons; Medicare provides health insurance benefits to persons over the age of 65 and others eligible for Social Security benefits. ( CSP )] (UMLS (CSP) C0596896) =Health Care Related Organization =health insurance;
income maintenance | - 372. mega
- [A prefix indicating a quantity of one million, 10E6. ( NCI )] (UMLS (HL7) C1553028) Mega-;
=Quantitative Concept =UnitOfMeasurePrefixInsens;
|
- 323. Medicated swab
- (UMLS (HL7) C0879059) =Medical Device =Swab;
| - 373. Megacaryoblast
- [The precursor of a megakaryocyte. ( NCI )] (UMLS (NCI) C0229650) =Cell ;
|
- 324. Medication (antibiotic)
- (UMLS (HL7) C1546901) =Classification =Diagnosis Classification;
| - 374. Megace
- (UMLS (NCI) C0700004) =Steroid; Pharmacologic Substance; Hormone
|
- 325. Medication abuse
- (UMLS (ICPC) C0260268) (Medication abuse; GAI MEDIKAMENTOSUEN ABUSUA; Medicinmisbrug; Geneesmiddel misbruik; LAAKKEEN VAARINKAYTTO; Abus de substance medicinale; Medikamentenmissbrauch; (108); gyogyszer abusus; Abuso di medicinali; MEDIKAMENTMISBRUK; Abuso de medicamentos; Abuso de farmacos; MEDICINMISSBRUK) =Mental or Behavioral Dysfunction =Symptoms and Complaints Component; PSYCHOLOGICAL
| - 375. Megacolon
- [Dilatation of the COLON, often to alarming dimensions. There are various types of megacolon including congenital megacolon in HIRSCHSPRUNG DISEASE, idiopathic megacolon in CONSTIPATION, and TOXIC MEGACOLON. ( MSH )] (UMLS (NCI) C0025160) =Disease or Syndrome =colon disorder;
=aganglionic megacolon;
Megacolon, Toxic;
|
- 326. medication category
- [ Definition:All information pertaining to a patient's medication records (orders, dispenses and other active medications). ( HL7V3.0 )] (UMLS (HL7) C1699698) =Intellectual Product =ActCode;
| - 376. MEGACOLON NEC
- [ ] (UMLS (ICD9CM) C0235904) =Disease or Syndrome
|
- 327. medication error
- [Errors in prescribing, dispensing, or administering medication with the result that the patient fails to receive the correct drug or the indicated proper drug dosage. ( MSH )] (UMLS (CSP) C0025115) =Qualitative Concept
| - 377. Megaesophagus
- (UMLS (NCI) C0025164) =Disease or Syndrome
|
- 328. medication history
- [Historical list of medications. ( HL7V3.0 )] (UMLS (HL7) C1553893) =Intellectual Product =medication list;
| - 378. MeGAG
- [ ] (UMLS (CSP) C0025716) =Organic Chemical; Pharmacologic Substance ;
|
- 329. medication list
- [List of medications. ( HL7V3.0 )] (UMLS (HL7) C1553891) =Idea or Concept =ActListCode;
=current medication list;
medication history;
discharge medication list;
| - 379. Megahertz
- [The SI derived unit of frequency; equal to one million oscillations per second or to 10E6 hertz. ( NCI )] (UMLS (NCI) C0556962) =Quantitative Concept
|
- 330. Medication, Treatment and Therapeutic Procedures Component
- (UMLS (ICPC) C0497527) (Medication, Treatment and Therapeutic Procedures Component; (194); (115); (116); (104); (105); (106); (108); (119); (133); (130); (122); (123)) =Intellectual Product =International Classification of Primary Care; =Altra procedura terapeutica; Farmaci/prescrizione/iniezione; ebakidura/drainaketa/garbiketa/aspirazioa/ziztada(perfusio-a-53); banaketa/esersia/biopsia/deuseztatzea/debridazioa/kauteriz-azioa; aparatuen aplikazioa/perfusioa/hodiztapena/zabalkuntza; Cura/sutura/escayola/protesis; helyi injekcio/infiltralas; apositoa/bendak/konpresioa/tanponamendua; fisioterapia/berronespena; Aconselhamento/escuta terapeutica;
| - 380. Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells
- (UMLS (NCI) C1334686) Megakaryoblasts 50% or More of Bone Marrow Nucleated Cells =Laboratory or Test Result
|
- 331. Medication/prescription/injection
- (UMLS (ICPC) C0497110) (Medication/prescription/injection; medikazio-agindua/eskaera/berriztapena/injekzioa; Medicinering/receptforny/inj syst; Medicatie/recept/injectie; LAAKEMAARAYS/INJEKTIO; Medication/prescription/injection; Medikation/Rezept/Injektion; (108); gyogyszereles/receptiras/inj.bead; Farmaci/prescrizione/iniezione; MEDIKASJ/FORNYET RESEPT/INJEKSJON; Medicacao/prescricao/injeccao; Solicitud/prescripcion fc/inyec; LAKEMEDEL/RECEPT/INJEKTION) Medication/prescript/injection =Therapeutic or Preventive Procedure =Medication, Treatment and Therapeutic Procedures Component;
| - 381. megakaryocyte
- [giant cell of bone marrow, a large cell with a greatly lobulated nucleus; mature blood platelets are released from its cytoplasm. ( CSP )] (UMLS (CSP) C0025166) =Cell =hematopoietic stem cell;
|
- 332. MedicationCap
- [Cap types for medication containers ( HL7V3.0 )] (UMLS (HL7) C1699285) =Classification =ContainerCap;
=EasyOpen;
ChildProof | - 382. Megakaryocyte Potentiating Factor
- [An antibody that reacts with ovarian cancers and mesotheliomas was used to isolate a cell surface antigen named mesothelin. Although the function of mesothelin is unknown, it may play a role in cellular adhesion and is present on mesothelium, mesotheliomas, and ovarian cancers. Three transcript variants have been described for this gene and their protein products were initially named megakaryocyte potentiating factor (MPF), mesothelin, and the soluble member(s) of the mesothelin/MPF family. The protein isoform named MPF is a cytokine with megakaryocyte potentiating activity. The soluble member encoded by the third splice variant is detected in ovarian carcinoma; the full length sequence of the third variant has not been described. (LocusLink) ( NCI )] (UMLS (NCI) C0380162) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 333. MedicationGeneralizationRoleType
- [Identifies the specific hierarchical relationship between the playing and scoping medications. Examples: Generic, Generic Formulation, Therapeutic Class, etc. ( HL7V3.0 )] (UMLS (HL7) C1697939) =Intellectual Product =RoleCode;
| - 383. Megakaryocytes Increased in Bone Marrow
- (UMLS (NCI) C0238800) =Finding
|
- 334. Medicinal Chemistry
- [A chemistry-based discipline, also involving aspects of biological, medical and pharmaceutical sciences. It is concerned with the invention, discovery, design, identification and preparation of biologically active compounds, the study of their metabolism, the interpretation of their mode of action at the molecular level and the construction of structure-activity relationships. ( NCI )] (UMLS (NCI) C0008003) =Biomedical Occupation or Discipline ;
| - 384. Megakaryocytic leukemia in remission
- (UMLS (ICD9CM) C0153914) =Neoplastic Process
|
- 335. medicinal plant
- [plant considered to possess healing properties. ( CSP )] (UMLS (CSP) C0032100) =Plant =plant;
=saw palmetto | - 385. Megakaryocytic leukemia without mention of remission
- (UMLS (ICD9CM) C0153913) =Neoplastic Process
|
- 336. Medihaler-Epi
- (UMLS (NCI) C0025133) =Organic Chemical; Pharmacologic Substance ;
| - 386. Megakaryocytic Neoplasm
- (UMLS (NCI) C1334687) Megakaryocytic Tumor =Neoplastic Process
|
- 337. MedImmune, Inc.
- [MedImmune, Inc. ( HL7V3.0 )] (UMLS (HL7) C1546879) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
VaccineManufacturer | - 387. Megakaryocytopoiesis
- [Megakaryopoiesis is the production of megakaryocytes in bone marrow that produce platelets. ( NCI )] (UMLS (NCI) C0522310) =Organ or Tissue Function
|
- 338. Medispan Diagnostic Codes
- [Codes Used for drug-diagnosis interaction checking. Proprietary product. Hierarchical drug codes for identifying drugs down to manufacturer and pill size. MediSpan, Inc., 8425 Woodfield Crossing Boulevard, Indianapolis, IN 46240. Tel: (800) 428-4495. WWW: http://www.espan.com/medispan/pages/ medhome.html. As above for MGPI. ( HL7V3.0 )] (UMLS (HL7) C1547153) =Intellectual Product =Code;
CodeSystem | - 388. Megaloblast
- [Red blood cell precursors, corresponding to ERYTHROBLASTS, that are larger than normal, usually resulting from a FOLIC ACID DEFICIENCY or VITAMIN B 12 DEFICIENCY. ( MSH )] (UMLS (NCI) C0025171) =Cell
|
- 339. Medispan GPI
- [Medispan hierarchical drug codes for identifying drugs down to manufacturer and pill size. Proprietary product of MediSpan, Inc., 8425 Woodfield Crossing Boulevard, Indianapolis, IN 46240. Tel: (800) 428-4495. ( HL7V3.0 )] (UMLS (HL7) C1547157) =Intellectual Product =Code;
CodeSystem | - 389. MEGALOBLASTIC ANEMIA NEC
- (UMLS (ICD9CM) C0302367) =Disease or Syndrome
|
- 340. meditation
- [state of consciousness in which the individual eliminates environmental stimuli from awareness so that the mind can focus on a single thing, producing a state of relaxation and relief from stress; a wide variety of techniques are used to clear the mind of stressful outside interferences; includes meditation as a therapy. ( CSP )] (UMLS (CSP) C0150277) =Mental Process =psychic activity level;
| - 390. Megaloblastic Erythroid Hyperplasia
- (UMLS (NCI) C1334688) =Finding
|
- 341. Meditation
- (UMLS (HL7) C1552052) =Idea or Concept =Religious Affiliation;
| - 391. Megestrol/Omega-3 Fatty acids
- (UMLS (NCI) C1134591) =Therapeutic or Preventive Procedure ;
|
- 342. Meditation
- [Continuous and profound contemplation or musing on a subject or series of subjects of a deep or abstruse nature; contemplation of spiritual matters ( NCI )] (UMLS (NCI) C0814263) Meditation Therapy =Therapeutic or Preventive Procedure
| - 392. MEGLITINIDE
- (UMLS (NCI) C0065880) =Organic Chemical; Pharmacologic Substance ;
|
- 343. Medium
- [Medium priority messages are available ( HL7V3.0 )] (UMLS (HL7) C1561547) =Qualitative Concept =Message Waiting Priority;
| - 393. MEGLUMINE
- [1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium. ( MSH )] (UMLS (NCI) C0025179) =Carbohydrate; Pharmacologic Substance ;
=Hexosamines;
D glucitol;
[AM900] ANTI-INFECTIVES, OTHER;
=1-Deoxy-1-(methylamino)-D-glucitol 3,5-diacetamido-2,4,6-triiodobenzoate (salt);
1-Deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate;
MEGLUMINE 0.39 MG/ML |
- 344. MEDIUM
- [Mid-way between small and large in number, quantity, magnitude or extent. ( NCI )] (UMLS (NCI) C0439536) =Quantitative Concept
| - 394. Meibomian Gland
- [The sebaceous glands situated on the inner surface of the eyelids between the tarsal plates and CONJUNCTIVA. ( MSH )] (UMLS (NCI) C0025181) =Body Part, Organ, or Organ Component
|
- 345. Medium extent
- [Value for Act.partialCompletionCode attribute that implies 41-60% completion ( HL7V3.0 )] (UMLS (HL7) C1555601) =Qualitative Concept =PartialCompletionScale;
| - 395. Meigs Syndrome
- [The triad of benign FIBROMA or other ovarian tumors with ASCITES, and HYDROTHORAX due to large PLEURAL EFFUSIONS. ( MSH )] (UMLS (NCI) C0025184) =Neoplastic Process =Neoplasm of Ovary;
|
- 346. Medium/Large Size Posterior Uveal Melanoma
- (UMLS (NCI) C0278868) =Neoplastic Process
| - 396. meiosis
- [special method of cell division, occurring in maturation of the germ cells, by means of which each daughter nucleus receives half the number of chromosomes characteristic of the somatic cells of the species. ( CSP )] (UMLS (NCI) C0025186) =Cell Function =growth/development;
Cellular Biology |
- 347. Medrol
- (UMLS (NCI) C0699458) =Steroid; Pharmacologic Substance
| - 397. Meiotic Recombination
- [Extensive Meiotic Recombination occurs during meiosis when the cell performs a round of DNA replication (meiS) followed by homolog synapsis and recombination that involves breakage of chromosomes or DNA molecules and rejoining of fragments in new combinations. ( NCI )] (UMLS (NCI) C1155792) =Cell Function
|
- 348. Medrol Veriderm
- (UMLS (NCI) C0065862) =Organic Chemical; Pharmacologic Substance ;
| - 398. MEIS1
- [This gene plays a role in embryonic development and cell differentiation. ( NCI )] (UMLS (NCI) C1334501) MEIS1 Gene;
MEIS1, Myeloid Ecotropic Viral Integration Site 1 Homolog (Mouse) Gene;
=Gene or Genome ;
|
- 349. Medrone
- (UMLS (NCI) C0591766) =Steroid; Pharmacologic Substance; Hormone
| - 399. MEL
- [RAB8 protein (MEL) contains the four GTP/GDP-binding sites present in all RAS proteins. The putative effector-binding site of MEL is similar to that of RAB/YPT proteins. However, MEL contains a C-terminal CAAX motif characteristic of many RAS superfamily members but which is not found in YPT1 and the majority of RAB proteins. Members of the RAS superfamily are small GTP/GDP-binding proteins. RAB/YPT family proteins may play a role in transport of proteins from the endoplasmic reticulum to the Golgi and the plasma membrane. (from OMIM 165040 and NCI) ( NCI )] (UMLS (NCI) C0218530) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 350. MEDRONIC ACID
- [A methylene-substituted bisphosphonate. Medronic acid has affinity for and adheres to the surface of hydroxyapatite crystals in the bone matrix. This agent accumulates at sites of osteoid mineralization and can be used, complexed with radioisotopes such as technetium 99m, in bone imaging. ( NCI )] (UMLS (NCI) C1366044) Methylenediphosphonic Acid;
=Organic Chemical; Pharmacologic Substance | - 400. Melacine
- (UMLS (NCI) C0761616) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
home
